drugset / Trial / NCT00800540

Circadian Ocular Perfusion Pressure and Ocular Blood Flow

NCT00800540

Phase 4 Completed 35 enrolled Alcon Research
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study was to compare the short term effects of two intraocular pressure (IOP) lowering medications on ocular perfusion pressure (OPP), ocular blood flow, intraocular pressure, and blood pressure in patients with glaucoma. Ocular perfusion pressure (OPP) is defined as the difference between arterial blood pressure (diastolic and systolic) and intraocular pressure. The primary efficacy assessment is based on diastolic ocular perfusion pressure.

Timeline

Start
2009-02
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 20 mg/ml Topical
Subject Brinzolamide Small molecule 10 mg/ml Topical
Background Timolol Other / unclassified 5 mg/ml Topical

Indications